Shots: The P-III OASIS-2 study involves assessing of Nuzyra (qd, PO) vs Linezolid (PO, bid) in 735 patients with acute bacterial skin and skin structure infections (ABSSSI) The P-III OASIS […]readmore
Tags : Nuzyra
Shots: The P-III OPTIC and OASIS-1 studies involves assessing of Nuzyra (Omadacycline) vs moxifloxacin & linezolid in 386 & 645 patients with community acquired bacterial pneumonia (CABP) & acute bacterial […]readmore
Regulatory
Paratek Pharmaceuticals’ Nuzyra (omadacycline) Receives FDA Approval for Community-Acquired Bacterial
Shots: The approval is based on multiple trial study assessing Nuzyra and resulted in safe, efficacious and well tolerated results Nuzyra (omadacycline) is a qd IV PO tetracycline class antibacterial […]readmore